港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

科倫博泰生物-B

285.400

-3.600-1.25%

成交量：81.19萬

成交額：2.33億

市值：647.86億

市盈率：-223.03

高：294.000

開：285.000

低：275.000

收：289.000

資料載入中...

總覽公司新聞公告

科倫博泰生物-B(06990)：核心產品蘆康沙妥珠單抗(sac-TMT)獲國家藥品監督管理局批准第二個適應症上市，用於EGFR突變非小細胞肺癌治療

科倫博泰生物(06990.HK)治療肺癌藥物獲國家藥監局批准第二個適應症

阿斯达克财经

《大行》滙豐研究升科倫博泰(06990.HK)目標價至260元評級“買入”

阿斯达克财经

科倫博泰生物-B盤中異動早盤快速拉昇5.02%報255.000港元

科倫博泰生物-B03月03日遭主力拋售2149萬元

國泰君安：國產創新藥全球競爭力凸顯經營拐點臨近

科倫博泰生物-B盤中異動急速上漲5.11%報242.800港元

國泰君安：維持科倫博泰生物-B“增持”評級核心產品步入商業化收穫期

國泰君安：維持科倫博泰生物-B(06990)“增持”評級核心產品步入商業化收穫期

科倫博泰生物-B盤中異動下午盤快速上漲5.25%報224.400港元

科倫博泰生物-B跌3.79% 股價跌破200港元大關

科倫博泰生物-B盤中異動快速下挫5.06%

科倫博泰生物-B02月20日主力資金流出44萬元連續3日減倉

科倫博泰生物-B02月19日遭主力拋售993萬元

中國內地投資者週二港股通淨買入額創四年來最高

野村：升科倫博泰生物-B(06990)目標價至211.87港元維持“買入”評級

科倫博泰生物-B02月17日主力資金流入246萬元連續3日加倉

科倫博泰生物與科倫嘉訊籤市場管理服務框架協議

科倫博泰生物-B盤中異動股價大跌5.07%

【港股通】科倫博泰生物(06990)將於美國臨牀腫瘤學會癌症研討會公佈核心產品研究成果

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06990/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科倫博泰生物-B","latestPrice":285.4,"timestamp":1744877289037,"preClose":289,"halted":0,"volume":811904,"delay":0,"floatShares":131000000,"shares":227000000,"eps":-1.2796556756154556,"marketStatus":"復活節星期一休市","change":-3.6,"latestTime":"04-17 16:08:09","open":285,"high":294,"low":275,"amount":232778521,"amplitude":0.065744,"askPrice":286.4,"askSize":300,"bidPrice":285.4,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-1.2796556756154556,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":289,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":1.0355934219983844,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":131000000,"roa":"-3.41%","roe":"-9.46%","lyrEps":-1.279656,"volumeRatio":1.0355934219983844,"shares":227000000,"dividePrice":0,"high":294,"amplitude":0.065744,"preClose":289,"low":275,"week52Low":120.2,"pbRate":"18.42","psRate":"31.52","week52High":346,"institutionHeld":0,"latestPrice":285.4,"eps":-1.2796556756154556,"divideRate":0,"volume":811904,"delay":0,"ttmEps":-1.2796556756154556,"open":285,"prevYearClose":163.3,"prevWeekClose":285.4,"prevMonthClose":290.8,"prevQuarterClose":290.8,"fiveDayClose":280.8,"twentyDayClose":259.4,"sixtyDayClose":162.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518151022","title":"科倫博泰生物-B(06990)：核心產品蘆康沙妥珠單抗(sac-TMT)獲國家藥品監督管理局批准第二個適應症上市，用於EGFR突變非小細胞肺癌治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2518151022","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518151022?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 16:47","pubTimestamp":1741596451,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B 发布公告，公司靶向人滋养细胞表面抗原2的抗体药物偶联物芦康沙妥珠单抗(佳泰莱)获国家药品监督管理局批准第二个适应症，用于治疗经表皮生长因子受体酪氨酸激酶抑制剂和含铂化疗治疗后进展的EGFR基因突变阳性的局部晚期或转移性非鳞状非小细胞肺癌成人患者。这是全球首个在肺癌适应症获批上市的TROP2ADC药物。与目前标准治疗相比，芦康沙妥珠单抗显著延长此类患者的总生存获益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2518804219","title":"科倫博泰生物(06990.HK)治療肺癌藥物獲國家藥監局批准第二個適應症","url":"https://stock-news.laohu8.com/highlight/detail?id=2518804219","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518804219?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 16:45","pubTimestamp":1741596300,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B公布，旗下靶向人滋养细胞表面抗原2的抗体药物偶联物芦康沙妥珠单抗，获国家药品监督管理局批准第二个适应症，用于治疗经表皮生长因子受体酪氨酸激酶抑制剂，和含铂化疗治疗后进展的EGFR基因突变阳性的局部晚期，或转移性非鳞状非小细胞肺癌成人患者。公告指，科伦博泰生物于2022年5月授予默沙东，在大中华区以外的所有地区开发、使用、制造及商业化芦康沙妥珠单抗的独家权利。沽空资料截至 2025-03-10 16:25。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1423454/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2517126635","title":"《大行》滙豐研究升科倫博泰(06990.HK)目標價至260元 評級“買入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2517126635","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517126635?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 12:04","pubTimestamp":1741320240,"startTime":"0","endTime":"0","summary":"汇丰研究的报告指，科伦博泰(06990.HK) 的SKB264已启动12项全球第三期临床研究，反映海外合作伙伴对SKB264的信心强劲。该行看好科伦博泰的SKB264商业化价值，认为其有利的竞争地位、强劲的临床证据，以及公司在医院及药房的庞大网络，均有助产品的销售增长，亦料SKB264可受惠于今年底国家医保药品目录对创新药物支持的讨论。该行调整对科伦博泰的亏损预测，预期2024至2026年分别录得净亏损5亿、9亿及5亿元人民币。对其目标价由237元上调至260元，维持“买入”评级。(vc/j)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-06 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161536655_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161536655_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1423001/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990"],"gpt_icon":0},{"id":"2517703719","title":"科倫博泰生物-B盤中異動 早盤快速拉昇5.02%報255.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517703719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517703719?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 09:31","pubTimestamp":1741224677,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘09时31分，科伦博泰生物-B股票出现波动，股价大幅上涨5.02%。截至发稿，该股报255.000港元/股，成交量4700股，换手率0.00%，振幅3.71%。资金方面，该股资金流入55.368万港元，流出55.472万港元。科伦博泰生物-B股票所在的生物技术行业中，整体涨幅为1.69%。其相关个股中，创胜集团-B、宜明昂科-B、科伦博泰生物-B涨幅较大，振幅较大的相关个股有百奥赛图-B、昭衍新药、康宁杰瑞制药-B，振幅分别为6.79%、4.15%、4.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306093117963b72b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306093117963b72b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2516688853","title":"科倫博泰生物-B03月03日遭主力拋售2149萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516688853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516688853?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 16:16","pubTimestamp":1740989819,"startTime":"0","endTime":"0","summary":"03月03日, 科伦博泰生物-B股价涨1.56%，报收234.60元，成交金额1.94亿元，换手率0.63%，振幅7.27%，量比1.31。科伦博泰生物-B今日主力资金净流出2149万元，上一交易日主力净流出413万元。该股近5个交易日上涨16.13%，主力资金累计净流出1764万元；近20日主力资金累计净流出1492万元，其中净流出天数为10日。该股主力净额占比0.07%，港股市场排名2582/2649。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165433a25cd41d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165433a25cd41d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2516577974","title":"國泰君安：國產創新藥全球競爭力凸顯 經營拐點臨近","url":"https://stock-news.laohu8.com/highlight/detail?id=2516577974","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516577974?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 14:00","pubTimestamp":1740981619,"startTime":"0","endTime":"0","summary":"国泰君安主要观点如下：全球竞争力凸显，经营扭亏拐点临近国产创新药逐渐展现出全球竞争力：据医药魔方统计，2024年在中国首发获批的新药达39款，占全球近40%，全球在研first in class新药中的国产品种占比已达24%，中国企业全年license-out交易的首付款和总金额分别达41亿和519亿美元。安徽省医保局发文将牵头2025年全国生物药品联盟集采，或将包括生物类似药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","BK0188","LU1969619763.USD","BK1588","BK1587","IE00B5MMRT66.SGD","601211","LU0348784397.USD","00013","09926","02611","BK1589","09969","BK0028","BK1147","BK1191","LU2488822045.USD","01801","BK0201","06160","06990","LU0588546209.SGD","159992","BK0184","BK1574","BK1564","LU0348783233.USD","BK1500","LU1794554557.SGD","IE00BPRC5H50.USD","BK1161","LU0196878994.USD","LU0307460666.USD","BK1583","LU1720050803.USD","LU2328871848.SGD","BK0276","BK0183","BK0012","LU0417516571.SGD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2516152068","title":"科倫博泰生物-B盤中異動 急速上漲5.11%報242.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516152068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516152068?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 10:21","pubTimestamp":1740968490,"startTime":"0","endTime":"0","summary":"2025年03月03日早盘10时21分，科伦博泰生物-B股票出现异动，股价快速上涨5.11%。截至发稿，该股报242.800港元/股，成交量11.85万股，换手率0.09%，振幅6.75%。资金方面，该股资金流入1566.82万港元，流出954.34万港元。科伦博泰生物-B股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，科笛-B、来凯医药-B、三叶草生物-B涨幅较大，振幅较大的相关个股有创胜集团-B、科笛-B、圣诺医药-B，振幅分别为20.41%、18.91%、12.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030310213198993d1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030310213198993d1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2514127378","title":"國泰君安：維持科倫博泰生物-B“增持”評級 核心產品步入商業化收穫期","url":"https://stock-news.laohu8.com/highlight/detail?id=2514127378","media":"新浪网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514127378?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 10:30","pubTimestamp":1740623423,"startTime":"0","endTime":"0","summary":"国泰君安发布研报称，维持科伦博泰生物-B“增持”评级。国泰君安主要观点如下：产品接连获批上市，首款国产TROP2ADC有望引领临床迭代公司核心产品芦康沙妥珠单抗于2024年11月获批上市，首发适应症为2线及以上TNBC；后续3L EGFRm NSCLC、2L EGFRmNSCLC已处于NDA阶段，有望2025年内陆续获批上市。作为首款获批上市的国产TROP2ADC，芦康沙妥珠单抗有望在乳腺癌、肺癌领域引领临床用药迭代。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022710540598944bc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022710540598944bc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","02611"],"gpt_icon":0},{"id":"2514811595","title":"國泰君安：維持科倫博泰生物-B(06990)“增持”評級 核心產品步入商業化收穫期","url":"https://stock-news.laohu8.com/highlight/detail?id=2514811595","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514811595?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 09:53","pubTimestamp":1740621224,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国泰君安发布研报称，维持科伦博泰生物-B“增持”评级。国泰君安主要观点如下：产品接连获批上市，首款国产TROP2ADC有望引领临床迭代公司核心产品芦康沙妥珠单抗于2024年11月获批上市，首发适应症为2线及以上TNBC;后续3L EGFRm NSCLC、2L EGFRm NSCLC已处于NDA阶段，有望2025年内陆续获批上市。此外，塔戈利单抗于2025年1月获批上市，用于鼻咽癌;西妥昔单抗生物类似药于2025年2月获批上市;博度曲妥珠单抗已处于NDA阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02611","06990"],"gpt_icon":0},{"id":"2514709410","title":"科倫博泰生物-B盤中異動 下午盤快速上漲5.25%報224.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514709410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514709410?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 13:25","pubTimestamp":1740547553,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘13时25分，科伦博泰生物-B股票出现波动，股价急速拉升5.25%。截至发稿，该股报224.400港元/股，成交量25.69万股，换手率0.20%，振幅7.60%。资金方面，该股资金流入3551.99万港元，流出1349.65万港元。科伦博泰生物-B股票所在的生物技术行业中，整体涨幅为1.90%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022613255398931655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022613255398931655&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2514450081","title":"科倫博泰生物-B跌3.79% 股價跌破200港元大關","url":"https://stock-news.laohu8.com/highlight/detail?id=2514450081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514450081?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 09:32","pubTimestamp":1740447137,"startTime":"0","endTime":"0","summary":"2025年02月25日早盘09时32分，科伦博泰生物-B股票出现波动，股价快速下跌3.79%。截至发稿，该股报198.000港元/股，成交量4800股，换手率0.00%，振幅3.89%。科伦博泰生物-B股票所在的生物技术行业中，整体跌幅为1.77%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225093217a252a264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225093217a252a264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2513719931","title":"科倫博泰生物-B盤中異動 快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513719931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513719931?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 15:33","pubTimestamp":1740382387,"startTime":"0","endTime":"0","summary":"2025年02月24日临近收盘15时33分，科伦博泰生物-B股票出现波动，股价大幅下跌5.06%。科伦博泰生物-B股票所在的生物技术行业中，整体跌幅为2.71%。其相关个股中，腾盛博药-B、创胜集团-B、永泰生物-B涨幅较大，振幅较大的相关个股有腾盛博药-B、方达控股、永泰生物-B，振幅分别为39.87%、26.57%、20.61%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224153307962e23c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224153307962e23c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2512413069","title":"科倫博泰生物-B02月20日主力資金流出44萬元 連續3日減倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2512413069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512413069?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 16:16","pubTimestamp":1740039382,"startTime":"0","endTime":"0","summary":"02月20日, 科伦博泰生物-B股价涨0.37%，报收188.80元，成交金额6143万元，换手率0.25%，振幅4.31%，量比0.63。科伦博泰生物-B今日主力资金净流出44万元，连续3日净流出，上一交易日主力净流出993万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为41.67%，平均跌幅为2.53%。该股近5个交易日上涨8.21%，主力资金累计净流出32万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出912万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220161727abd5dead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220161727abd5dead&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2512781071","title":"科倫博泰生物-B02月19日遭主力拋售993萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512781071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512781071?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 16:16","pubTimestamp":1739952995,"startTime":"0","endTime":"0","summary":"02月19日, 科伦博泰生物-B股价涨0.32%，报收188.10元，成交金额7748万元，换手率0.31%，振幅3.15%，量比0.81。科伦博泰生物-B今日主力资金净流出993万元，上一交易日主力净流出75万元。该股近5个交易日上涨5.60%，主力资金累计净流入356万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出828万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219161732a24b991c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219161732a24b991c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2512111961","title":"中國內地投資者週二港股通淨買入額創四年來最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111961","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512111961?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 07:37","pubTimestamp":1739921873,"startTime":"0","endTime":"0","summary":"中国内地投资者周二通过港股通净买入224亿港元的香港股票，继续推动DeepSeek引发的科技股涨势。彭博数据显示，这是自2021年初以来最大单日净买入，也是有纪录以来第四高。恒生科技指数当日大涨2.5%，有望连续第六周上涨。内地资金大量涌入香港股市，已推动A股市场相较港股的溢价幅度缩小至约34%，这使得一项A-H股溢价指数接近在过去总会触发反弹的底部，引发了香港上市中资股跑赢内地股票的幅度可能缩小的担忧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06808","00762","00392","02382","00288","01929","02386","06616","02291","00826","06618","00189","01530","01675","01952","01341","02099","09696","00939","01128","01787","02105","03918","02172","09688","00013","00836","03969","01818","03800","00293","01357","02883","09987","01066","09988","03396","02607","02155","01686","00270","02400","02338","06690","02162","09868","00006","01772","02208","06680","01519","00152","01405","01735","02269","02465","00856","02618","00659","00666","00467","01618","00008","00981","00751","01119","03968","02186","00003","09969","00425","01070","01876","00855","02057","09880","00144","00175","01211","00590","09926","00548","00303","01513","00148","02096","02533","01093","00991","01177","02402","01691","01921","01907","01855","02018","06060","02005","03311","01810","00177","00576","00371","02380","06821","02015","00220","00014","02333","00777","02121","03618","02688","00327","06198","09858","00512","03606","BK1536","01199","01558","06699","02367","02171","03360","00853","01347","03692","09992","BK1133","09995","06855","00772","HSCEI","06069","02268","02498","09890","00241","06160","BK1506","01789","02601","01071","00107","00384","02016","SG9999002463.SGD","03933","00300","03650","01585","02158","00316","00868","01193","01860","00038","09626","01112","06127","09923","00788","00861","00005","00867","03690","00257","03369","02282","03988","06818","01138","01310","02359","01963","BK1589","02600","01658","02157","00267","00728","01919","06110","01766","00317","HSTECH","09922","09885","00546","01052","03328","00142","00412","06181","06990","01579","03888","06186","01024","01888","06936","00819","09899","01541"],"gpt_icon":0},{"id":"2512139119","title":"野村：升科倫博泰生物-B(06990)目標價至211.87港元 維持“買入”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2512139119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512139119?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 17:05","pubTimestamp":1739869514,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，野村发布研报称，维持科伦博泰生物-B“买入”评级，基于DCF估值，上调其目标价8.4%，由195.51港元升至211.87港元。同时野村还预测2024年下半年，科伦博泰生物收入为3.45亿元人民币，净亏损为4.78亿元人民币。野村研报指出，由于科伦博泰生物授权收入减少，下调其2025年销售预估，将其2024-2025年收入预测分别下调14.8%/10.6%，均降至17亿人民币。然而，基于宏观环境改善以及集团在商业和临床方面取得的进展，上调了集团2026年后的收入和盈利预测。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1251153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990"],"gpt_icon":0},{"id":"2512112619","title":"科倫博泰生物-B02月17日主力資金流入246萬元 連續3日加倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2512112619","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512112619?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 16:17","pubTimestamp":1739780248,"startTime":"0","endTime":"0","summary":"02月17日, 科伦博泰生物-B股价跌0.60%，报收181.40元，成交金额9821万元，换手率0.41%，振幅6.96%，量比1.41。科伦博泰生物-B今日主力资金净流入246万元，连续3日净流入，上一交易日主力净流入830万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为69.23%，平均涨幅为4.52%。该股近5个交易日上涨0.06%，主力资金累计净流入206万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入475万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217161838abd1f55d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217161838abd1f55d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2510732690","title":"科倫博泰生物與科倫嘉訊籤市場管理服務框架協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2510732690","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510732690?lang=zh_tw&edition=fundamental","pubTime":"2025-02-12 17:50","pubTimestamp":1739353837,"startTime":"0","endTime":"0","summary":"财中社2月12日电科伦博泰生物-B（06990）发布公告，2025年2月12日，公司与科伦嘉讯签订市场管理服务框架协议，科伦嘉讯及其联属人士将为公司研发的重组表皮生长因子受体（EGFR）人鼠嵌合单克隆抗体西妥昔单抗N01注射液提供市场管理服务。该协议的有效期为2025年2月12日至2025年12月31日，年度上限为3500万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502123317398771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2510447258","title":"科倫博泰生物-B盤中異動 股價大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510447258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510447258?lang=zh_tw&edition=fundamental","pubTime":"2025-02-11 10:24","pubTimestamp":1739240675,"startTime":"0","endTime":"0","summary":"2025年02月11日早盘10时24分，科伦博泰生物-B股票出现波动，股价急速下跌5.07%。截至发稿，该股报172.100港元/股，成交量7.94万股，换手率0.06%，振幅5.07%。资金方面，该股资金流入388.638万港元，流出885.097万港元。科伦博泰生物-B股票所在的生物技术行业中，整体跌幅为0.78%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211102436a24142e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211102436a24142e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2510848794","title":"【港股通】科倫博泰生物(06990)將於美國臨牀腫瘤學會癌症研討會公佈核心產品研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2510848794","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510848794?lang=zh_tw&edition=fundamental","pubTime":"2025-02-11 08:58","pubTimestamp":1739235513,"startTime":"0","endTime":"0","summary":"金吾财讯 | 科伦博泰生物 宣布，公司将在于2025年2月13日至15日举行的2025年美国临床肿瘤学会泌尿生殖系统癌症研讨会上，公布其抗人滋养细胞表面抗原2的抗体药物偶联物芦康沙妥珠单抗(佳泰莱)单药治疗既往接受过抗癌疗法时或治疗后病情进展的不可切除、局部晚期或转移性尿路上皮癌患者的1/2期KL264-01/MK-2870-001研究的疗效及安全性结果。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/NjM1YWNhMGUzZGNhNThhMTg4MzM5MDkyOTUwOA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NjM1YWNhMGUzZGNhNThhMTg4MzM5MDkyOTUwOA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952855","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","BK1161","06990","LU0196878994.USD","HSCEI","YANG"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2941,"buy":0.7059,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7059,"analysts":17,"updateTime":1744646400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2025-04-17","current":-228.611836,"percent":0.03653,"low":-257.850518,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"high":-21.029201,"avg":-97.473315,"sd":62.021902,"marketCap":64862287200},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200}],"updateTime":1745156687961}}}